Cite
HARVARD Citation
Macaluso, F. et al. (n.d.). P612 Lack of seroconversion following COVID-19 vaccination, but not treatment, is an independent risk factor for breakthrough SARS-CoV-2 infection in patients with inflammatory bowel disease: data from ESCAPE - an IG-IBD Study. Journal of Crohn's and colitis. p. i741. [Online].